FDFadime Demir

Fadime Demir

*This is an algorithmically generated author record based on publicly available information.

Fadime Demir has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tc-99m DMSA Radiomics in CKD: Phenotype-Specific Cortical Signatures and a Morphological Predictor of Renal Function Decline

    by Mustafa Demir, Nihat Köylüce, Davut Eren, Koray Uludağ, Hümeyra Gençer, Seyhan Karaçavuş, Fadime Demir

    Purpose: This study aims to evaluate the ability of radiomic features obtained from technetium-99m dimercaptosuccinic acid (Tc-99m DMSA) planar images to distinguish renal cortical uptake patterns among patients with chronic kidney disease (CKD). We also assessed the association between selected radiomic features and progressive renal function loss during follow-up. Methods: The study included a total of 185 patients: patients with Diabetes mellitus (DM) + hypertension (HTN) diagnosis (Group 1, n = 30), patients with HTN diagnosis alone (Group 2, n = 86), and patients with no history of DM or HTN who were followed for CKD (Group 3, n = 69). Intergroup comparisons were performed using the Kruskal–Wallis test with Bonferroni-corrected post hoc pairwise testing; the proportion of significantly different features was assessed using FDR correction. As a secondary exploratory analysis, the relationship between selected radiomic features and time to first observed ≥20% eGFR decline at follow-up was evaluated using univariate L2-penalised Cox proportional hazards regression with feature selection guided by the events-per-variable principle and model discrimination quantified using Harrell’s C-index. Results: Intensity Kurtosis values showed a statistically significant difference among the groups: −0.11 (−0.31 to 0.12) for Group 1, −0.24 (−0.41 to −0.04) for Group 2, and −0.33 (−0.45 to −0.16) for Group 3 (p = 0.001). Mean Intensity values were found to be 60.66 (31.01–89.39) in Group 1 and 90.46 (72.87–106.34) in Group 3 (p < 0.001). Age, gender, and baseline eGFR did not differ between groups. Radiomic analysis revealed significant intergroup differences predominantly in intensity- and texture-based features, while morphological features showed more limited differentiation. In the secondary exploratory longitudinal analysis, Centre of Mass Shift was the only morphological feature significantly associated with time to first observed ≥20% eGFR decline at follow-up (HR per SD: 0.74; 95% CI: 0.58–0.94; p = 0.015; C-index: 0.57). Conclusions: Radiomic features from Tc-99m DMSA planar images reveal quantitative differences between clinically defined CKD subgroups even when cortical uptake appears visually indistinguishable. The threshold-specific association of Centre of Mass Shift with subsequent eGFR decline, beyond baseline renal function, suggests that DMSA radiomics may provide exploratory prognostic information that warrants prospective validation.

  • Vitamin D Modulates Doxorubicin‐Induced ACE2 Expression and Pro‐Inflammatory Cytokines in the Rat Tongue

    by Mustafa Sami Demirsoy, Aras Erdil, Sefa Çolak, Ali Tuğrul Akin, Necla Değer, Derya Karabulut, Fadime Demir, Hatice Aygün

    Purpose: Doxorubicin (DOX) is a widely used chemotherapy drug, but its severe toxic effects, including inflammation and taste disturbances, limit its clinical use. This study examined the protective effects of vitamin D on DOX‐induced changes in tongue tissue and systemic inflammation in rats. Methods: Twenty‐eight adult male Wistar Albino rats (10–12 weeks old) were divided into four groups: Control, DOX, Vitamin D 5000 + DOX, and Vitamin D 60 000 + DOX. Vitamin D3 was administered intraperitoneally either daily (5000 IU/kg) or 3 days a week (60 000 IU/kg) for 21 days. DOX (18 mg/kg, intraperitoneally) was administered on days 19–21. Tongue tissues were analyzed for angiotensin‐converting enzyme 2 (ACE2) expression via immunohistochemistry, and serum cytokine levels (TNF‐α, IL‐1β, and IL‐6) were measured using enzyme‐linked immunosorbent assay (ELISA). Results: DOX treatment significantly increased ACE2 expression in tongue tissue compared with controls ( p < 0.001), accompanied by elevated serum inflammatory cytokine levels and reduced body weight. Vitamin D supplementation significantly attenuated DOX‐induced ACE2 upregulation and inflammatory cytokine elevations ( p < 0.05). However, no clear dose‐dependent difference was observed between the two vitamin D regimens, as ACE2 expression did not differ significantly between the 5000 IU/kg and 60 000 IU/kg groups. Conclusion: DOX administration is associated with increased ACE2 expression in tongue tissue and systemic inflammation in a rat model. Vitamin D supplementation mitigates these DOX‐induced alterations; however, within the tested dose range, no additional benefit of the higher vitamin D dose was demonstrated. These findings suggest a potential modulatory role of vitamin D on chemotherapy‐associated inflammatory and molecular changes, while highlighting the need for further mechanistic and functional studies.

  • Can 68Ga-PSMA-11 PET/CT renal uptake parameters predict renal function impairment?

    by Fadime Demir, Mustafa Demir, Seyhan Karaçavuş, Muhammet İkbal Yeşilyurt, Mahmut Burak Laçin

    The aim is to investigate the correlation between renal maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), molecular kidney volume (MKV), and total kidney uptake (TKU), which are indicators of the PSMA kidney uptake pattern in 68Ga-PSMA-11 PET/CT imaging and kidney function tests. We secondarily aim to investigate how accurately renal parameters obtained from 68Ga-PSMA-11 PET/CT can provide information about the patient's kidney functions. The study included 196 patients with prostate cancer who underwent 68Ga-PSMA-11 PET/CT imaging for staging purposes. Semiquantitative analyses were performed on the kidneys in the PET/CT images, and renal SUVmax, SUVmean, MKV, TKU values, as well as anatomical kidney volume (CT-KV) from CT imaging, were calculated. The patients' concurrent laboratory results, including eGFR, BUN, and creatinine levels, were recorded. Statistical analyses were performed using the SPSS 22 software. The Spearman test was used to determine the correlation between the parameters. The ANOVA test was used for intergroup comparisons, and the Tamhane test was used for post-hoc analyses. When comparing eGFR, BUN, and creatinine values with PET/CT renal parameters, a significant correlation was found between eGFR and MKV (r = 0.397), TKU (r = 0.271), and CT-KV (r = 0.216). Similar correlations were also observed for BUN and creatinine. When patients were grouped based on eGFR values, Group 1 (eGFR > 90; normal) included 75 patients, Group 2 (eGFR: 89-60; mild reduction) included 98 patients, and Group 3 (eGFR: 59-30; moderate reduction) included 21 patients. Significant differences were observed between the groups in terms of TKU, MKV, and CT-KV. In post-hoc analyses, the most significant parameter was MKV. 68Ga-PSMA-11 PET/CT-derived renal parameters, particularly the molecular kidney volume (MKV), exhibit a significant positive correlation with renal function and demonstrate a significant decrease in patients with renal dysfunction compared to those with normal renal function.


  • Open Access

    Relationship between tumor parameters in Ga-68 PSMA PET/CT and pathological grade grouping in patients with prostate cancer

    by F. Demir, S. Karaçavuş, H. Gençer, A. Özdal, Z. Erdoğan, İ. Çiftçi, F. Çevik Kaya, N. Özhan, H. İşçi, M. Kaya

    Background: The study aims to explore the relationship between tumor parameters acquired from Ga-68 PSMA PET/CT and GG system in patients who had prostate cancer. Materials and Methods: One hundred and fourteen patients diagnosed with prostate cancer and who underwent Ga-68 PSMA PET/CT imaging for staging purposes were enrolled. The ...

  • An Investigation of the Relationship Between 18F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer

    by Ozan Kandemir, Fadime Demir

    Background: Mediastinal lymph node metastasis is an important prognostic factor in non-small cell lung cancer (NSCLC) patients without distant metastases. 18F-2-fluoro-2-deoxy-Dglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) is recommended for detecting and staging lymph nodes and distant metastases in NSCLC patients. Objective: This study aims to investigate whether maximum standardized uptake (SUVmax), mean standardized uptake (SUVmean), metabolic tumor volume (MTV), and tumor lesion glycolysis (TLG) values of the primary tumor measured by 18F-FDG PET/CT in resectable NSCLC can predict preoperative lymph node metastasis. Methods: This retrospective study included eighty NSCLC patients who underwent preoperative Positron Emission Tomography/Computed Tomography (PET/CT) for diagnosis and staging. The patients were stage I–III and had no distant metastases. Tumor metabolic parameters such as SUVmax, SUVmean, MTV, and TLG at PET/CT imaging were measured for preoperative diagnosis and staging, and the postoperative pathology results of the patients were examined. The pathology results divided patients into two groups; with and without lymph node metastasis. The groups were compared with student's t-test and chi-square test with regard to 18F-FDG PET/CT tumor metabolic parameters and other parameters. Results: Fifteen (18.8%) patients were female, and 65 (81.3%) were male. According to the postoperative pathology results, while 30 (37.5%) patients had lymph node metastasis, 50 (62.5%) did not. There was a significant difference between the groups regarding tumor SUVmax and SUVmean values (p = 0.036, p = 0.045). Overall survival in the N0 group was significantly higher than in the N1 + N2 group (p = 0.034); median survival was 30.2 months in N0 group and 27.3 months in N1 and N2 groups. Conclusion: SUVmax and SUVmean values are significantly higher in patients with lymph node metastases than in patients without lymph node metastases, and this finding may provide useful information for predicting lymph node metastasis in patients with resectable NSCLC.


  • THE ROLE OF PET CT IN CANCER OF UNKNOWN PRIMARY

    by Ozan Kandemi̇r, Fadime Demi̇r

    Objective: This study aimed to investigate the diagnostic value of positron emission tomography/computed tomography (PET/CT) in detecting the primary focus and in suspicious foci in patients who underwent PET/CT with a pre-diagnosis of carcinoma of unknown primary. Material and Methods: In this retrospective study, a total of 49 patients who underwent PET/CT scan with a prediagnosis of carcinoma of the unknown primary between 2015 and 2019, and whose clinical follow-up and histopathological data were available, were included.PET/CT study was performed in 20 (40%) patients after the metastatic lesion was detected as a result of pathology, and in 29 (60%) patients due to clinical findings and imaging methods and suspicion of malignancy. The histopathological and clinical evaluation of the patients before PET/CT and the primary surgery, histopathological examinations and clinical follow-ups after PET/CT were examined. The success of PET/CT in detecting primary lesions and evaluating suspicious lesions in metastatic cases was analyzed. Results: Seventeen (34.7%) of the patients were female and 32 (65.3%) were male. A primary malignant tumor was detected in 34 (85%) of 40 patients with PET/CT. Regional distribution in patients with primary cancer focus; 9 pancreases, 9 lungs, 4 livers, 3 urothelial, 2 thyroids, 1 vertebra, 1 breast, 1 ovary, 1 esophagus, 1 prostate, 1 iliac bone, 1 skin, 1 stomach and 1 colon. In the follow-up of 6 cases whose primary could not be determined; Cervical cancer was detected in 1, ovarian cancer in 1, and the primary focus could not be detected in the clinical follow-up of 4 metastatic patients. Conclusion: PET/CT is highly successful in detecting cancers whose primary is unknown. Therefore, PET/CT is a diagnostic imaging method for the detection of the primary in cancer patients whose primary is unknown. Keywords: Cancer of unknown primary; Positron emission tomography; Malignant lesion

  • Open Access

    Karaciğer, Pankreas, Safra Yolları Cerrahisinde Temel Konular ve Tedavide Güncel Yaklaşımlar

    by Yakup Tatar, Emre Turgut, Sevi Karabulut Uzunçakmak, Pınar Gündoğan Bozdağ, Fadime Demir, Tuba Erürker Öztürk, Kubilay Dalcı, Şirin Menekşe, Haydar Öcal, Umut Tüysüz, et al.

    Kitabımızın oluşturulmasında en belirleyici etken olan “Bilimsel düşünce ve üretmek” adına bizleri yetiştiren ve bu vizyonu kazandıran; fakülte sıralarından asistanlığımızın sonuna ve uzmanlık yıllarımıza dek katkıları olan, bizlere bu yolu açan çok değerli hocalarımıza öncelikle teşekkürlerimi sunarım. Mesleki olarak yararlandığımız ve bizlere faydalı olan uluslararası branş kitaplarının yanında, ülke kaynaklarımız ve tıp dünyamıza ait tecrübelerin, bilimsel çalışmaların referans alınarak meslektaşlarımıza yansıtıldığı ve katkı sunmasını amaçladığımız bu çalışmamızın değerli meslektaşlarımız ve hocalarımıza faydalı olmasını dilerim.